Whales with a lot of money to spend have taken a noticeably bullish stance on Annovis Bio.
Looking at options history for Annovis Bio ANVS we detected 12 trades.
If we consider the specifics of each trade, it is accurate to state that 58% of the investors opened trades with bullish expectations and 41% with bearish.
From the overall spotted trades, 8 are puts, for a total amount of $385,983 and 4, calls, for a total amount of $139,780.
Expected Price Movements
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $2.5 to $12.5 for Annovis Bio during the past quarter.
Analyzing Volume & Open Interest
In terms of liquidity and interest, the mean open interest for Annovis Bio options trades today is 2744.8 with a total volume of 26,113.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Annovis Bio's big money trades within a strike price range of $2.5 to $12.5 over the last 30 days.
Annovis Bio 30-Day Option Volume & Interest Snapshot
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ANVS | PUT | SWEEP | BEARISH | 07/19/24 | $0.6 | $0.5 | $0.6 | $2.50 | $96.9K | 3.6K | 7.9K |
| ANVS | PUT | SWEEP | BEARISH | 07/19/24 | $0.6 | $0.5 | $0.6 | $2.50 | $84.3K | 3.6K | 5.5K |
| ANVS | PUT | SWEEP | BULLISH | 07/19/24 | $0.6 | $0.55 | $0.55 | $2.50 | $66.0K | 3.6K | 3.3K |
| ANVS | CALL | SWEEP | BULLISH | 06/21/24 | $2.0 | $1.85 | $2.0 | $10.00 | $37.6K | 1.1K | 118 |
| ANVS | CALL | TRADE | BULLISH | 10/18/24 | $2.65 | $2.0 | $2.5 | $12.50 | $37.5K | 55 | 150 |
About Annovis Bio
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
In light of the recent options history for Annovis Bio, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Annovis Bio's Current Market Status
- Currently trading with a volume of 1,012,901, the ANVS's price is up by 6.46%, now at $8.9.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 90 days.
What The Experts Say On Annovis Bio
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $26.333333333333332.
- Maintaining their stance, an analyst from HC Wainwright & Co. continues to hold a Buy rating for Annovis Bio, targeting a price of $23.
- In a cautious move, an analyst from HC Wainwright & Co. downgraded its rating to Buy, setting a price target of $30.
- Consistent in their evaluation, an analyst from Canaccord Genuity keeps a Buy rating on Annovis Bio with a target price of $26.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Annovis Bio options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
